Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-amino-3-hydroxybutanoic Acid
2. 80-68-2
3. 7004-04-8
4. Dl-2-amino-3-hydroxybutanoic Acid
5. H-dl-allo-thr-oh
6. 144-98-9
7. H-dl-thr-oh
8. Dl-allothreonine
9. 2-amino-3-hydroxy-butanoic Acid
10. Dl-allo-threonine
11. Allothreonine, D-
12. 760pjt2ss0
13. Chebi:38263
14. Butanoic Acid, 2-amino-3-hydroxy-
15. Wln: Qy1&yzvq -l
16. Threonine #
17. Allothreonine, L-
18. Butanoic Acid, [r-(r*,s*)]-
19. Allothreonine, Dl-
20. 29nap6417f
21. Theronine
22. Laevo-threonine
23. Nsc46701
24. Mfcd00004526
25. Mfcd00063722
26. Mfcd00064268
27. Mfcd00064269
28. Nsc-41828
29. Nsc-46702
30. Nsc-206267
31. Nsc-206283
32. Nsc-206292
33. Ncgc00164520-01
34. Ncgc00164520-02
35. Einecs 205-645-3
36. Threonine,(l)
37. Schembl1479
38. Unii-760pjt2ss0
39. 2-amino-3-hydroxybutanoicacid
40. Chembl30037
41. Unii-29nap6417f
42. Dtxsid301015364
43. Amy25310
44. Bcp16820
45. Nsc16589
46. Nsc41828
47. Nsc46702
48. Bbl011585
49. Mfcd00066665
50. Nsc 41828
51. Nsc206267
52. Nsc206283
53. Nsc206292
54. Stl163323
55. Akos000118925
56. Akos016042347
57. Butyric Acid, Alpha-amino-beta-hydroxy-
58. As-14237
59. Dl-threonine (contains Dl-allothreonine)
60. Sy018620
61. Sy020053
62. Sy024226
63. Sy026984
64. L-threonine 2-amino-3-hydroxybutyric Acid
65. Db-047492
66. Db-054434
67. A0214
68. Cs-0154977
69. Ft-0601219
70. Ft-0604667
71. Ft-0604670
72. Ft-0624367
73. Ft-0625423
74. Ft-0625521
75. Ft-0675201
76. T0229
77. T3105
78. Thr
79. A20656
80. (2r,s),(3s,r)-2-amino-3-hydroxybutyric Acid
81. 066a665
82. 2-amino-3-hydroxybutanoic Acid (h-dl-xithr-oh)
83. A808305
84. Sr-01000944947
85. J-008036
86. Sr-01000944947-1
87. Butyric Acid, .alpha.-amino-.beta.-hydroxy-
88. F3ab6ce6-3cf9-4c81-a7d7-7c21f24fdc0e
89. Q27117433
90. Q60662943
91. Z57127549
92. F2191-0228
93. 4-chloro-8-(trifluoromethyl)quinoline-3-carboxylicethylester
94. (s)-threonine;l-alpha-amino-beta-hydroxybutyric Acid;l-threonin;threonin
95. 36676-50-3
Molecular Weight | 119.12 g/mol |
---|---|
Molecular Formula | C4H9NO3 |
XLogP3 | -2.9 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 119.058243149 g/mol |
Monoisotopic Mass | 119.058243149 g/mol |
Topological Polar Surface Area | 83.6 Ų |
Heavy Atom Count | 8 |
Formal Charge | 0 |
Complexity | 93.3 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1318
Submission : 1969-01-23
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1318
Submission : 1969-01-23
Status : Inactive
Type : II
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Cicatrin Powder 15G
Dosage Form : POR
Dosage Strength : 250u/g
Packaging : 15X1u/g
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?